Contact

Representative before the EPO

Employment test 51 - 200 employees
Company dna boult wade tennant ltd
operating since 1894
Headquarter in London and 5 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 8 EP applications Sharon Claire Baldock has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 23, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12187075

Biomarker normalization

IPC classification:
G01N 13/04
Applicant:
University of California
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Agent:
Multiple attorneys, Fish & Richardson PC
Status:
EXAMINATION IN PROGRESS
EP11778725

METHODS FOR ASSESSING AND IDENTIFYING OR EVOLVING CONDITIONALLY ACTIVE THERAPEUTIC PROTEINS

IPC classification:
C07K 16/30, G01N 33/53, G01N 33/574, G01N 33/68
Applicant:
Halozyme Inc
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
EXAMINATION IN PROGRESS
EP12192296

Method for preparing of monodisperse oligo ethylene glycol

IPC classification:
C08G 65/329, C08G 65/337, C08G 65/34, A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
GRANT OF PATENT INTENDED
EP13155667

OLIGOMER-OPIOID AGONIST CONJUGATES

IPC classification:
A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
PATENT GRANTED
EP12811896

LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USE THEREOF

IPC classification:
A61P 29/00, C08B 37/00, A61K 31/715, A61K 35/74
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
GRANT OF PATENT INTENDED
EP13155670

Oligomer-opioid agonist conjugates

IPC classification:
A61K 47/48
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11749018

CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF

IPC classification:
C08G 77/50, C08L 83/14
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13152053

CD40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity

IPC classification:
C07K 14/555, C07K 14/705, C07K 16/28, C12N 1/20, C12N 5/10, A61K 39/245, A61K 39/285, A61K 39/39, A61K 47/48, A61K 48/00
Applicant:
The Regents of the University of Colorado
Agent:
Sharon Claire Baldock, Boult Wade Tennant Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature